1.Tonotopic organization of intracochlear nerve.
Jin Young KIM ; H FRED ; Joon Sik MIN ; Dong Myung LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 1991;34(1):15-21
No abstract available.
2.Neural stem cells: mechanisms and modeling.
Jun YAO ; Yangling MU ; Fred H GAGE
Protein & Cell 2012;3(4):251-261
In the adult brain, neural stem cells have been found in two major niches: the dentate gyrus and the subventricular zone [corrected]. Neurons derived from these stem cells contribute to learning, memory, and the autonomous repair of the brain under pathological conditions. Hence, the physiology of adult neural stem cells has become a significant component of research on synaptic plasticity and neuronal disorders. In addition, the recently developed induced pluripotent stem cell technique provides a powerful tool for researchers engaged in the pathological and pharmacological study of neuronal disorders. In this review, we briefly summarize the research progress in neural stem cells in the adult brain and in the neuropathological application of the induced pluripotent stem cell technique.
Hippocampus
;
cytology
;
metabolism
;
Humans
;
Induced Pluripotent Stem Cells
;
cytology
;
metabolism
;
Models, Biological
;
Neural Stem Cells
;
cytology
;
metabolism
;
transplantation
;
Neurodegenerative Diseases
;
metabolism
;
pathology
;
prevention & control
;
Neurogenesis
;
Signal Transduction
3.Validation of a method for the determination of thiocyanate in human plasma by UV/VIS spectrophotometry and application to a Phase I clinical trial of GDC-0425.
Young G SHIN ; Henri MEIJERING ; Fred H VAN HEUVELN ; Jaap WIELING ; Jason HALLADAY ; Srikumar SAHASRANAMAN ; Cornelis E C A HOP
Translational and Clinical Pharmacology 2015;23(2):59-65
The development and validation of a method for the determination of concentrations of thiocyanate in human plasma are described here. A modified colorimetric method of Bowler was used with the following alteration in Monica Manual, Part III. In order to obtain the same sensitivity in low amounts of clinical samples, quartz SUPRASIL(R) micro cuvettes have been used. The quantitation range was between 25-500 microM. Accuracy and precision of the quality control samples, linearity of the calibration curve, dilution, spike recovery and stability under various conditions were evaluated in the validation of the method and all demonstrated acceptable results. All validation results met good laboratory practice acceptance and FDA requirements to be acceptable for application in clinical trials. The validated method has been used for a Phase I clinical study in cancer patients orally administered with either 60 mg or 80 mg of GDC-0425 containing a cyanide (CN-) group. The thiocyanate levels from patients before and after drug administration showed no clinically significant differences.
Calibration
;
Humans*
;
Plasma*
;
Quality Control
;
Quartz
;
Spectrophotometry*
4.Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol
W. Frank PEACOCK ; Alan S. MAISEL ; Christian MUELLER ; Stefan D. ANKER ; Fred S. APPLE ; Robert H. CHRISTENSON ; Paul COLLINSON ; Lori B. DANIELS ; Deborah B. DIERCKS ; Salvatore Di SOMMA ; Gerasimos FILIPPATOS ; Gary HEADDEN ; Brian HIESTAND ; Judd E. HOLLANDER ; Juan C. KASKI ; Joshua M. KOSOWSKY ; John T. NAGURNEY ; Richard M. NOWAK ; Donald SCHREIBER ; Gary M. VILKE ; Marvin A. WAYNE ; Martin THAN
Clinical and Experimental Emergency Medicine 2022;9(2):140-145
Objective:
To determine the utility of a highly sensitive troponin assay when utilized in the emergency department.
Methods
The FAST-TRAC study prospectively enrolled >1,500 emergency department patients with suspected acute coronary syndrome within 6 hours of symptom onset and 2 hours of emergency department presentation. It has several unique features that are not found in the majority of studies evaluating troponin. These include a very early presenting population in whom prospective data collection of risk score parameters and the physician’s clinical impression of the probability of acute coronary syndrome before any troponin data were available. Furthermore, two gold standard diagnostic definitions were determined by a pair of cardiologists reviewing two separate data sets; one that included all local troponin testing results and a second that excluded troponin testing so that diagnosis was based solely on clinical grounds. By this method, a statistically valid head-to-head comparison of contemporary and high sensitivity troponin testing is obtainable. Finally, because of a significant delay in sample processing, a unique ability to define the molecular stability of various troponin assays is possible.Trial registration ClinicalTrials.gov Identifier NCT00880802
5.Hormone levels following surgical and medical castration: defining optimal androgen suppression.
Michael T SCHWEIZER ; Michael L HANCOCK ; Robert H GETZENBERG ; Evan Y YU
Asian Journal of Andrology 2018;20(4):405-406
Aged
;
Aged, 80 and over
;
Androgen Antagonists/pharmacology*
;
Androgens/blood*
;
Cohort Studies
;
Gonadotropin-Releasing Hormone/antagonists & inhibitors*
;
Hormones/blood*
;
Humans
;
Luteinizing Hormone/blood*
;
Male
;
Middle Aged
;
Orchiectomy
;
Prostatic Neoplasms/surgery*
;
Toremifene/therapeutic use*
6.Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma.
Na QIN ; Yuancheng LI ; Cheng WANG ; Meng ZHU ; Juncheng DAI ; Tongtong HONG ; Demetrius ALBANES ; Stephen LAM ; Adonina TARDON ; Chu CHEN ; Gary GOODMAN ; Stig E BOJESEN ; Maria Teresa LANDI ; Mattias JOHANSSON ; Angela RISCH ; H-Erich WICHMANN ; Heike BICKEBOLLER ; Gadi RENNERT ; Susanne ARNOLD ; Paul BRENNAN ; John K FIELD ; Sanjay SHETE ; Loic LE MARCHAND ; Olle MELANDER ; Hans BRUNNSTROM ; Geoffrey LIU ; Rayjean J HUNG ; Angeline ANDREW ; Lambertus A KIEMENEY ; Shan ZIENOLDDINY ; Kjell GRANKVIST ; Mikael JOHANSSON ; Neil CAPORASO ; Penella WOLL ; Philip LAZARUS ; Matthew B SCHABATH ; Melinda C ALDRICH ; Victoria L STEVENS ; Guangfu JIN ; David C CHRISTIANI ; Zhibin HU ; Christopher I AMOS ; Hongxia MA ; Hongbing SHEN
Frontiers of Medicine 2021;15(2):275-291
Although genome-wide association studies have identified more than eighty genetic variants associated with non-small cell lung cancer (NSCLC) risk, biological mechanisms of these variants remain largely unknown. By integrating a large-scale genotype data of 15 581 lung adenocarcinoma (AD) cases, 8350 squamous cell carcinoma (SqCC) cases, and 27 355 controls, as well as multiple transcriptome and epigenomic databases, we conducted histology-specific meta-analyses and functional annotations of both reported and novel susceptibility variants. We identified 3064 credible risk variants for NSCLC, which were overrepresented in enhancer-like and promoter-like histone modification peaks as well as DNase I hypersensitive sites. Transcription factor enrichment analysis revealed that USF1 was AD-specific while CREB1 was SqCC-specific. Functional annotation and gene-based analysis implicated 894 target genes, including 274 specifics for AD and 123 for SqCC, which were overrepresented in somatic driver genes (ER = 1.95, P = 0.005). Pathway enrichment analysis and Gene-Set Enrichment Analysis revealed that AD genes were primarily involved in immune-related pathways, while SqCC genes were homologous recombination deficiency related. Our results illustrate the molecular basis of both well-studied and new susceptibility loci of NSCLC, providing not only novel insights into the genetic heterogeneity between AD and SqCC but also a set of plausible gene targets for post-GWAS functional experiments.
Adenocarcinoma of Lung/genetics*
;
Carcinoma, Non-Small-Cell Lung/genetics*
;
Carcinoma, Squamous Cell/genetics*
;
Genetic Heterogeneity
;
Genetic Predisposition to Disease
;
Genome-Wide Association Study
;
Humans
;
Lung Neoplasms/genetics*
;
Polymorphism, Single Nucleotide